Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
Authors:
- 17 March 2018
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 196 (3) , 351-358
Abstract
The purpose of this study is to assess temporal trends in population-based treatment and survival rates in patients with early-stage non-small cell lung cancer (NSCLC).Keywords
This publication has 33 references indexed in Scilit:
- Results of Initial Low-Dose Computed Tomographic Screening for Lung CancerNew England Journal of Medicine, 2013
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010
- Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLCJournal of Thoracic Oncology, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsJournal of Clinical Oncology, 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Comparison of aspects of smoking among the four histological types of lung cancerTobacco Control, 2008
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985